Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Alembic Pharmaceuticals with status Current. The shortage was first posted on Mar 23, 2018.
Shortage details
- Status
- Current
- Company
- Alembic Pharmaceuticals
- Package NDC
- 62332-601-25
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)
- Initial Posting
- Mar 23, 2018